Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells()()

Acquiring therapy resistance is one of the major obstacles in the treatment of patients with cancer. The discovery of the cancer stem cell (CSC)–specific drug salinomycin raised hope for improved treatment options by targeting therapy-refractory CSCs and mesenchymal cancer cells. However, the occurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopp, Florian, Hermawan, Adam, Oak, Prajakta Shirish, Ulaganathan, Vijay Kumar, Herrmann, Annika, Elnikhely, Nefertiti, Thakur, Chitra, Xiao, Zhiguang, Knyazev, Pjotr, Ataseven, Beyhan, Savai, Rajkumar, Wagner, Ernst, Roidl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311025/
https://www.ncbi.nlm.nih.gov/pubmed/25500079
http://dx.doi.org/10.1016/j.tranon.2014.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311025/
https://www.ncbi.nlm.nih.gov/pubmed/25500079
http://dx.doi.org/10.1016/j.tranon.2014.09.002

Ejemplares similares